Global IVF Services Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Cycle Type;
Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor) and Donor Egg IVF Cycles.By End User;
Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global IVF Services Market (USD Million), 2021 - 2031
In the year 2024, the Global IVF Services Market was valued at USD 17,664.51 million. The size of this market is expected to increase to USD 34,095.89 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.9%.
The global in vitro fertilization (IVF) services market has witnessed remarkable growth over the past few decades, driven by various factors such as technological advancements, increasing infertility rates, and growing awareness about assisted reproductive technologies (ART). IVF procedures involve fertilizing an egg with sperm outside the body, typically in a laboratory setting, and then implanting the embryo into the uterus. This technique has revolutionized the treatment of infertility and has offered hope to millions of couples struggling to conceive naturally.
One of the key factors fueling the growth of the global IVF services market is the rising prevalence of infertility worldwide. Factors such as lifestyle changes, delayed childbearing, environmental factors, and underlying health conditions have contributed to the growing incidence of infertility among both men and women. As a result, there has been a surge in demand for assisted reproductive technologies, including IVF, to help couples achieve pregnancy and fulfill their desire for parenthood.
Advancements in IVF technology have significantly improved success rates and reduced the risks associated with infertility treatments. Innovations such as preimplantation genetic testing (PGT), time-lapse imaging, and embryo culture systems have enhanced the efficiency and accuracy of IVF procedures, resulting in higher pregnancy rates and healthier outcomes for both mothers and babies. Additionally, the increasing availability of specialized fertility clinics, skilled healthcare professionals, and supportive regulatory frameworks in many countries have further propelled the growth of the IVF services market.
Despite the significant advancements and growing demand, the high cost of IVF treatments remains a major challenge for many couples seeking fertility assistance. IVF procedures can be financially burdensome, particularly for those without insurance coverage or in regions where access to affordable fertility care is limited. Efforts to address these cost barriers, along with ongoing research and development aimed at improving treatment outcomes and expanding access to care, are expected to shape the future trajectory of the global IVF services market.
Global IVF Services Market Recent Developments
-
In 2023, Hamilton Thorne Nederland BV completed the acquisition of Gynetics MP NV and Gynetics S, BV, expanding its operations into more profitable dealings within the mature European ART market.
-
In 2023, Esco acquired CMT Materials, LLC and its affiliate Engineered Syntactic Systems, LLC, thereby including the critical equipment for the development and production of materials in order to further enhance the basket of products offered by Esco.
Segment Analysis
The global in vitro fertilization (IVF) services market has experienced significant growth over the past few years, driven by factors such as increasing infertility rates, advancements in assisted reproductive technology (ART), and changing lifestyles. IVF procedures have become a mainstream solution for couples struggling with infertility issues, contributing to the expansion of the market. Moreover, the rising trend of delayed parenthood due to career demands and lifestyle choices has further fueled the demand for IVF services, particularly in developed regions.
Technological innovations and advancements in IVF procedures have led to higher success rates and improved outcomes, attracting more couples towards these treatments. Techniques such as intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and cryopreservation have revolutionized the field of reproductive medicine, providing more options for couples undergoing IVF. Additionally, the growing acceptance of third-party reproduction, including egg and sperm donation as well as surrogacy, has expanded the scope of IVF services, making it a comprehensive solution for various fertility challenges.
Geographically, North America and Europe dominate the global IVF services market, owing to factors such as higher healthcare expenditure, favorable reimbursement policies, and advanced healthcare infrastructure. However, emerging economies in Asia Pacific, Latin America, and the Middle East are witnessing rapid growth in the adoption of IVF services due to improving healthcare facilities, increasing awareness about infertility treatments, and changing societal norms. Furthermore, strategic collaborations between fertility clinics, healthcare providers, and pharmaceutical companies are expected to drive further growth in the global IVF services market, offering enhanced services and comprehensive solutions to patients worldwide.
Global IVF Services Segment Analysis
In this report, the Global IVF Services Market has been segmented by Cycle Type, End User and Geography.
Global IVF Services Market, Segmentation by Cycle Type
The Global IVF Services Market has been segmented by Cycle Type into Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor) and Donor Egg IVF Cycles.
One of the primary segments within this market is Fresh IVF Cycles (Non-donor). These cycles involve the retrieval of eggs from the female partner, fertilization with sperm in a laboratory setting, and subsequent transfer of resulting embryos into the uterus. Fresh cycles are often preferred for their potential higher success rates and the use of a patient's own genetic material.
Another key segment is Thawed IVF Cycles (Non-donor), which involves the use of previously frozen embryos from either a fresh IVF cycle or from a donor. This segment offers advantages such as flexibility in timing and reduced medication costs compared to fresh cycles. Thawed cycles have gained popularity due to advancements in cryopreservation techniques, which have improved the survival rates of frozen embryos.
The market includes Donor Egg IVF Cycles, catering to individuals or couples facing challenges with egg quality or quantity. In these cycles, eggs from a donor are fertilized with sperm and the resulting embryos are transferred to the recipient's uterus. Donor egg cycles provide an alternative pathway to parenthood for those unable to conceive using their own eggs, and they have contributed significantly to expanding access to IVF services globally.
Global IVF Services Market, Segmentation by End User
The Global IVF Services Market has been segmented by End User into Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes.
Fertility clinics represent a substantial segment within the market, offering specialized services and expertise tailored to assist couples struggling with infertility issues. These clinics provide a range of treatments, including in vitro fertilization (IVF), intrauterine insemination (IUI), and other assisted reproductive technologies (ART), catering to the diverse needs of patients seeking fertility assistance.
Hospitals also play a crucial role in the IVF services market, often offering comprehensive reproductive health services alongside other medical specialties. With advanced infrastructure and a multidisciplinary approach, hospitals provide a wide array of fertility treatments to patients, ensuring accessibility and convenience. Moreover, hospitals may serve as referral centers for complex cases, collaborating with fertility clinics and specialists to deliver integrated care.
Surgical centers represent another key segment in the IVF services market, providing specialized facilities for reproductive surgeries and procedures. These centers offer a focused environment equipped with state-of-the-art technology and a skilled surgical team, ensuring optimal outcomes for patients undergoing fertility-related surgeries such as egg retrieval, embryo transfer, and tubal ligation reversal.
Clinical research institutes contribute significantly to the advancement of IVF technologies and treatment protocols. Engaged in pioneering research and development initiatives, these institutes drive innovation in the field of reproductive medicine, fostering the evolution of IVF techniques and enhancing success rates. Through clinical trials and academic collaborations, research institutes contribute valuable insights and evidence-based practices, shaping the future landscape of IVF services.
Global IVF Services Market, Segmentation by Geography
In this report, the Global IVF Services Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global IVF Services Market Share (%), by Geographical Region, 2024
North America holds a prominent position in the global IVF services market, attributed to factors such as high healthcare expenditure, favorable reimbursement policies, and advanced healthcare infrastructure. Additionally, the region boasts a high prevalence of infertility, further propelling market growth. The presence of key market players and ongoing research and development activities contribute to the region's dominance in the global IVF services market.
Europe is another significant market for IVF services, with countries like Germany, France, and the UK leading in terms of market share. Increasing awareness about fertility treatments, coupled with supportive government initiatives, drives market growth in this region. Moreover, the rise in delayed pregnancies due to changing lifestyle patterns contributes to the demand for IVF services across Europe.
The Asia Pacific region is experiencing rapid growth in the IVF services market due to factors such as the increasing prevalence of infertility, rising disposable income, and improving healthcare infrastructure. Countries like China, India, and Japan are witnessing a surge in demand for IVF services, driven by factors such as delayed pregnancies, changing lifestyles, and the growing acceptance of ART procedures.
The Middle East and Africa, along with Latin America, are emerging markets for IVF services, propelled by factors such as improving healthcare facilities, rising awareness about infertility treatments, and the growing acceptance of ART procedures. However, challenges such as limited access to healthcare facilities and cultural stigmas associated with infertility hinder market growth to some extent in these regions.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global IVF Services Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers:
- Advancements in reproductive technology
- Increasing infertility rates globally
- Rising demand for assisted reproduction
-
Growing acceptance of IVF treatments: The global in-vitro fertilization (IVF) services market has experienced significant growth over the past decade, driven by a growing acceptance of IVF treatments worldwide. IVF has emerged as a mainstream solution for couples struggling with infertility, offering hope where traditional methods have failed. Advancements in technology, coupled with increasing awareness and acceptance of reproductive assistance, have fueled the expansion of the IVF services market.
One key factor contributing to the growing acceptance of IVF treatments is the rising prevalence of infertility issues globally. Factors such as delayed childbearing, lifestyle changes, and environmental factors have led to an increase in infertility rates across different regions. As a result, more individuals and couples are turning to IVF as a viable option to fulfill their desire for parenthood. Additionally, societal shifts toward greater acceptance and support for diverse family structures have reduced the stigma associated with assisted reproductive technologies, making IVF a more accessible and socially acceptable choice for many.
Advancements in IVF technology have improved success rates and expanded the scope of treatment options available to patients. Innovations such as preimplantation genetic testing (PGT), time-lapse imaging, and embryo vitrification have revolutionized the field of assisted reproduction, offering higher chances of successful pregnancy outcomes and reducing the emotional and financial burden on patients. These technological advancements have also attracted a broader demographic of patients, including single individuals, LGBTQ+ couples, and those with medical conditions that previously posed challenges to conception.
Restraints:
- High cost of IVF procedures
- Ethical and legal concerns
- Limited insurance coverage
-
Cultural stigmas and barriers: The global IVF (In Vitro Fertilization) services market is experiencing significant growth, driven by various factors such as increasing infertility rates, advancements in reproductive technologies, and growing awareness and acceptance of IVF procedures. However, cultural stigmas and barriers continue to pose challenges to widespread adoption and access to IVF services in many parts of the world.
In some cultures, there exists a stigma surrounding infertility and assisted reproductive technologies like IVF. Infertility is often seen as a taboo topic, and couples facing fertility issues may experience shame, guilt, or social ostracization. This stigma can discourage individuals from seeking IVF treatments, leading to delayed or inadequate care. Additionally, cultural beliefs and norms regarding family structure, gender roles, and reproductive health can influence attitudes towards IVF, creating barriers to acceptance and utilization of these services.
Accessibility and affordability of IVF services vary widely across different cultures and regions. Socioeconomic factors, including income level, education, and healthcare infrastructure, play a significant role in determining access to IVF treatments. Cultural attitudes towards healthcare, insurance coverage, and government regulations also impact the availability and affordability of IVF services. Addressing cultural stigmas and barriers requires a multifaceted approach, including education, advocacy, and policy interventions to promote acceptance, affordability, and equitable access to IVF services globally.
Opportunities:
- Emerging markets adoption
- Technological innovations in IVF
- Increasing fertility tourism
-
Expanding fertility preservation services: The global in-vitro fertilization (IVF) services market has witnessed significant expansion in recent years, driven in part by the increasing demand for fertility preservation services. Fertility preservation has become a crucial aspect of reproductive healthcare, especially for individuals facing medical treatments like chemotherapy that may compromise their fertility. As awareness about fertility issues grows and societal attitudes toward family planning evolve, more people are seeking IVF services not only for immediate conception but also to preserve their fertility for future use. This trend has spurred the development of advanced techniques and technologies in the field of assisted reproductive technology (ART), further fueling the growth of the IVF services market.
Factors such as delayed parenthood due to career pursuits, changing lifestyles, and socio-economic factors contribute to the growing demand for fertility preservation services. The increasing prevalence of conditions such as polycystic ovary syndrome (PCOS) and endometriosis, which can affect fertility, also drives the need for IVF services. Additionally, advancements in IVF technology, including preimplantation genetic testing (PGT) and cryopreservation techniques, have enhanced success rates and expanded the scope of IVF services, attracting more individuals and couples seeking fertility solutions. Consequently, the global IVF services market is experiencing a notable expansion, with fertility preservation services playing a significant role in driving this growth trajectory.
The disruption caused by the pandemic, including delays in elective medical procedures and concerns about the impact of the virus on pregnancy, has prompted many to explore fertility preservation options through IVF services. This heightened awareness, coupled with advancements in telemedicine and remote monitoring technologies, has facilitated greater access to IVF services, including fertility preservation consultations and procedures, further propelling market expansion. Looking ahead, the global IVF services market is poised for continued growth, driven by evolving societal norms, technological innovations, and the increasing prioritization of reproductive health and family planning.
Competitive Landscape Analysis
Key players in Global IVF Services Market include:
- The Cooper Companies, Inc
- Vitrolife AB
- Cook Medical Inc
- Irvine Scientific
- Thermo Fisher Scientific Inc
- Merck KGaA
- Genea Limited
- Boston Scientific Corporation
- Progyny, Inc
- Ferring Pharmaceuticals
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Cycle Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global IVF Services Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Advancements in reproductive technology
- Increasing infertility rates globally
- Rising demand for assisted reproduction
- Growing acceptance of IVF treatments
- Restraints
- High cost of IVF procedures
- Ethical and legal concerns
- Limited insurance coverage
- Cultural stigmas and barriers
- Opportunities
- Emerging markets adoption
- Technological innovations in IVF
- Increasing fertility tourism
- Expanding fertility preservation services
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global IVF Services Market, By Cycle Type, 2021 - 2031 (USD Million)
- Fresh IVF Cycles (Non-donor)
- Thawed IVF Cycles (Non-donor)
- Donor Egg IVF Cycles
- Global IVF Services Market, By End User, 2021 - 2031 (USD Million)
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
- Global IVF Services Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- North America
- Global IVF Services Market, By Cycle Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- The Cooper Companies, Inc
- Vitrolife AB
- Cook Medical Inc
- Irvine Scientific
- Thermo Fisher Scientific Inc
- Merck KGaA
- Genea Limited
- Boston Scientific Corporation
- Progyny, Inc
- Ferring Pharmaceuticals
- Company Profiles
- Analyst Views
- Future Outlook of the Market